# Citations for Research Query

**Query:** # Mechanistic Hypothesis Search

You are evaluating a specific disease mechanism hypothesis for the Disorder
Mechanisms Knowledge Base. This is not a general disease overview. Use the
hypothesis YAML below as the seed claim, then search for evidence that supports,
refutes, qualifies, or competes with this hypothesis.

## Target Disease
- **Disease Name:** Reelin Terminal Translocation and Cortical Lamination Failure Module
- **Category:** Module

## Target Hypothesis
- **Hypothesis ID:** reelin_terminal_translocation_model
- **Hypothesis Label:** Reelin Terminal Translocation and Lamination Model
- **Status in KB:** CANONICAL

## Seed Hypothesis YAML

```yaml
hypothesis_group_id: reelin_terminal_translocation_model
hypothesis_label: Reelin Terminal Translocation and Lamination Model
status: CANONICAL
description: Reelin secreted by Cajal-Retzius cells in the marginal zone binds VLDLR and ApoER2/LRP8 on
  migrating neurons, activating DAB1 and downstream adhesion and cytoskeletal effectors. Failure of this
  signal impairs glia-independent somal translocation and leading-process stabilization, so late and early
  cortical neurons fail to settle in the proper inside-out order. The same pathway also organizes hippocampal
  and cerebellar development, explaining the recurring association of cortical lamination defects with
  hippocampal and cerebellar hypoplasia or disorganization.
evidence:
- reference: PMID:27445693
  supports: SUPPORT
  evidence_source: OTHER
  snippet: Reelin is a large secreted glycoprotein that is essential for correct neuronal positioning
    during neurodevelopment and is important for synaptic plasticity in the mature brain.
  explanation: Review evidence summarizes Reelin as an essential secreted cue for neuronal positioning.
- reference: PMID:27445693
  supports: SUPPORT
  evidence_source: OTHER
  snippet: In the brain, many of Reelin's functions are mediated by a molecular signaling cascade that
    involves two lipoprotein receptors, apolipoprotein E receptor-2 (Apoer2) and very low density-lipoprotein
    receptor (Vldlr), the neuronal phosphoprotein Disabled-1 (Dab1), and members of the Src family of
    protein tyrosine kinases as crucial elements.
  explanation: Defines the core receptor-adaptor cascade used as this module's central skeleton.
- reference: PMID:21315259
  supports: SUPPORT
  evidence_source: MODEL_ORGANISM
  snippet: Thus, we define the cellular mechanism of reelin function during radial migration, elucidate
    the molecular pathway downstream of Dab1 during somal translocation, and establish the importance
    of glia-independent motility in neocortical development.
  explanation: Primary mouse and slice-culture experiments connect Reelin/Dab1 signaling to somal translocation
    and neocortical development.
```

## Research Objective

Build a focused hypothesis-search report that answers:

1. What is the strongest direct evidence for this hypothesis?
2. What evidence argues against it, fails to reproduce it, or limits its scope?
3. Which claims are established, emerging, speculative, or contradicted?
4. Which patient subtypes, stages, tissues, cell types, molecular pathways, or
   biomarkers does the hypothesis best explain?
5. Which alternative or competing mechanistic hypotheses explain the same disease
   features better or more parsimoniously?
6. What are the explicit knowledge gaps: missing causal steps, unconfirmed edges,
   contradictory evidence, unknown source-to-target links, or source/data absences?
7. What experiments, cohorts, assays, datasets, or trials would most directly
   distinguish this hypothesis from alternatives?

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews as orientation unless they
contain directly relevant synthesized evidence that should be clearly labeled as
review-level support.

## Required Output

### Executive Judgment

Give a concise verdict on the hypothesis as of the current literature:
supported, partially supported, unresolved, weakly supported, or refuted. Explain
the reasoning and the most important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (human clinical, model organism, in vitro, computational, review)
- Supports / refutes / qualifies / competing
- Mechanistic claim tested
- Key finding
- Disease subtype or context
- Confidence and limitations

### Mechanistic Causal Chain

Describe the causal chain implied by the hypothesis from upstream trigger to
clinical manifestation. Identify where the literature is strong, where the links
are inferred, and where there are missing causal steps.

### Knowledge Gaps

Identify explicit known unknowns surfaced by the search. Treat absence of
evidence as a curation-relevant finding only when the search actually checked for
it. Include:

- Unknown or weakly supported causal steps in the hypothesis
- Unconfirmed causal graph edges that need direct perturbation or longitudinal
  evidence
- Conflicting evidence, failed replications, or incompatible subtype-specific
  findings
- Unknown mechanism of action for relevant treatments, biomarkers, or
  interventions tied to this hypothesis
- Source-level or dataset-level absences, such as no relevant GenCC, ClinGen,
  trial, omics, or cohort evidence found as of the search date

For each gap, state the scope, why it matters, what was checked, and what
evidence or experiment would resolve it.

### Alternative Models

List competing or complementary hypotheses. For each, explain whether it is an
alternative to the seed hypothesis, a downstream consequence, an upstream cause,
or a parallel mechanism.

### Discriminating Tests

Recommend concrete studies or assays that would most efficiently test this
hypothesis against alternatives. Include patient stratification, biomarkers,
sample type, model system, perturbation, and expected result where applicable.

### Curation Leads

Provide candidate updates for the KB, but label these as leads requiring curator
verification. Include:

- candidate evidence references and exact abstract snippets to verify
- candidate pathophysiology nodes or edges
- candidate ontology terms for cell types and biological processes
- candidate subtype restrictions or status changes
- candidate `knowledge_gaps` or discussion prompts for unresolved causal claims,
  conflicting evidence, or explicit source/data absences

If the provider supports artifacts, produce artifact-friendly outputs such as an
evidence matrix, mechanistic diagram, knowledge-gap table, or comparison table.
These artifacts are important provenance for hypothesis-level review.

**Provider:** falcon
**Generated:** 2026-06-09T22:41:48.259483

1. franco2011reelinregulatescadherin pages 1-2
2. jossin2020reelinfunctionsmechanisms pages 11-12
3. boycott2005homozygousdeletionof pages 1-2
4. ha2017cterminalregiontruncation pages 9-11
5. riva2024denovomonoallelic pages 12-13
6. riva2024denovomonoallelic pages 14-15
7. jossin2020reelinfunctionsmechanisms pages 8-11
8. ha2017cterminalregiontruncation pages 4-6
9. ha2017cterminalregiontruncation pages 4-4
10. riva2024denovomonoallelic pages 7-10
11. ha2017cterminalregiontruncation pages 1-2
12. riva2024denovomonoallelic pages 1-2
13. ozcelik2008mutationsinthe pages 1-3
14. boycott2009mutationsinvldlr pages 1-2
15. ha2017cterminalregiontruncation pages 6-8
16. ha2017cterminalregiontruncation pages 8-9
17. riva2024denovomonoallelic pages 2-3
18. franco2011reelinregulatescadherin pages 11-12
19. riva2024denovomonoallelic pages 3-4
20. ozcelik2008mutationsinthe pages 3-4
21. boycott2009mutationsinvldlr pages 4-5
22. boycott2009mutationsinvldlr pages 2-4
23. riva2024denovomonoallelic pages 13-14
24. https://doi.org/10.1086/444400
25. https://doi.org/10.1212/nxg.0000000000000558
26. https://doi.org/10.1523/eneuro.0433-22.2023
27. https://doi.org/10.1172/jci153097
28. https://doi.org/10.1016/j.neuron.2011.01.003
29. https://doi.org/10.1523/jneurosci.1826-16.2016
30. https://doi.org/10.1073/pnas.0710010105
31. https://doi.org/10.1177/0883073809332696
32. https://doi.org/10.3390/biom10060964
33. https://doi.org/10.1016/j.neuron.2011.01.003,
34. https://doi.org/10.1523/jneurosci.1826-16.2016,
35. https://doi.org/10.1523/eneuro.0433-22.2023,
36. https://doi.org/10.1172/jci153097,
37. https://doi.org/10.3390/biom10060964,
38. https://doi.org/10.1086/444400,
39. https://doi.org/10.1073/pnas.0710010105,
40. https://doi.org/10.1177/0883073809332696,
41. https://doi.org/10.1212/nxg.0000000000000558,
